{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:40:05Z","timestamp":1792089605350,"version":"4.4.0"},"reference-count":149,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am Soc Clin Oncol Educ Book"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Alterations in the mitogen-activated protein kinase (MAPK) pathway play a central role in colorectal cancer (CRC) tumor biology, therapeutic response, and resistance.\n                      <jats:italic toggle=\"yes\">RAS<\/jats:italic>\n                      oncogenic mutations are present in up to 35% of CRC; they represent constitutively active molecular switches that impair GTP hydrolysis and promote ligand-independent signaling. The development of allele-specific KRAS G12C inhibitors exploits a cryptic pocket to trap the protein in its inactive (OFF) conformation. In metastatic CRC, where EGFR feedback loop limits monotherapy efficacy, combinations of KRAS G12C inhibitors with EGFR blockade and chemotherapy have demonstrated meaningful activity. Parallel efforts allowed the development of RAS(ON) inhibitors that sterically block the interaction with downstream effectors. Co-occurring genomic alterations, MAPK pathway reactivation, and pharmacologic limitations drive primary and acquired resistance.\n                      <jats:italic toggle=\"yes\">BRAF V600<\/jats:italic>\n                      mutations drive approximately 10% of CRCs; first-generation, type I BRAF inhibitors require combination with upstream EGFR, downstream MEK\/ERK blockade to overcome adaptive feedback reactivation. Emerging strategies include paradox breaking RAF inhibitors, type II pan-RAS inhibitors, and immunotherapy combinations, particularly relevant for the immune-activated phenotype of BRAF-mutant microsatellite stable tumors. Beyond\n                      <jats:italic toggle=\"yes\">RAS<\/jats:italic>\n                      and\n                      <jats:italic toggle=\"yes\">RAF<\/jats:italic>\n                      , novel therapeutic avenues (such as antibody-drug conjugates, bispecific antibodies, DNA damage response inhibitors, and tumor microenvironment modulating agents) are reshaping precision oncology in CRC. Integrating multiomics profiling with dynamic biomarkers may enable durable activity and personalized treatment strategies.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1200\/edbk-26-516576","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T19:59:12Z","timestamp":1777060752000},"source":"Crossref","is-referenced-by-count":5,"title":["Emerging and Established Targets in Colorectal Cancer: Translating Biology Into Therapeutics"],"prefix":"10.1200","volume":"46","author":[{"given":"Rafael","family":"Grochot","sequence":"first","affiliation":[{"name":"Sarah Cannon Research Institute (SCRI), London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Bartolini","sequence":"additional","affiliation":[{"name":"USC Norris Comprehensive Cancer Center, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Algaze","sequence":"additional","affiliation":[{"name":"USC Norris Comprehensive Cancer Center, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Reimann","sequence":"additional","affiliation":[{"name":"Academic Teaching Hospital Feldkirch, Internal Medicine II, Hematology and Medical Oncology, Feldkirch, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Winder","sequence":"additional","affiliation":[{"name":"Academic Teaching Hospital Feldkirch, Internal Medicine II, Hematology and Medical Oncology, Feldkirch, Austria"},{"name":"University of Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz-Josef","family":"Lenz","sequence":"additional","affiliation":[{"name":"USC Norris Comprehensive Cancer Center, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Fontana","sequence":"additional","affiliation":[{"name":"Sarah Cannon Research Institute (SCRI), London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.aad6204"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2007.05.018"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-025-01166-3"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-024-01631-9"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-020-0068-6"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.28550"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2009.07.010"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/90.9.675"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.2001.1964"},{"key":"e_1_3_2_11_2","first-page":"957","article-title":"Not all mutations of KRAS predict poor prognosis in patients with colorectal cancer","volume":"12","author":"Li W","year":"2019","unstructured":"Li W, Liu Y, Cai S, et al: Not all mutations of KRAS predict poor prognosis in patients with colorectal cancer. Int J Clin Exp Pathol 12:957, 2019","journal-title":"Int J Clin Exp Pathol"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/onco.13870"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2017.37"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.3892\/mco.2017.1149"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2011.26"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2014.2411"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0804385"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.14.7116"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-016-1382-7"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2015.04.007"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.3390\/genes12060899"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-021-02225-w"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2030638"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clcc.2020.04.009"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-022-00334-z"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-21-0201"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2103695"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2204619"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-20-0187"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110993"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00605-7"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2212419"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-24-0217"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO-24-02026"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(25)00352-3"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02696-8"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2023.09.1741"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2025.43.16_suppl.3508"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2025.43.16_suppl.3507"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2025.43.4_suppl.191"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2023.41.16_suppl.3513"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2025.43.16_suppl.3506"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2024.08.574"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2025.43.4_suppl.TPS326"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02717-6"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1398419"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2303810"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-22-0405"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.15724"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-87486-3"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2105281"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2308795"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2025.01.020"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2023-2308"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06123-3"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-15-0203"},{"key":"e_1_3_2_57_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41589-022-01083-7"},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41589-022-01065-9"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.4c02314"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2025-CT019"},{"key":"e_1_3_2_61_2","unstructured":"KAL-21404358 | Benchchem https:\/\/www.benchchem.com\/product\/b12955137#kal-21404358-off-target-effects-in-cancercell-lines"},{"key":"e_1_3_2_62_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41421-021-00368-w"},{"key":"e_1_3_2_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2024.107886"},{"key":"e_1_3_2_64_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17050785"},{"key":"e_1_3_2_65_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2025-086026"},{"key":"e_1_3_2_66_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature23291"},{"key":"e_1_3_2_67_2","doi-asserted-by":"publisher","unstructured":"Bhamidipati D Pellatt A Subbiah V: Targeting all BRAF alterations: The (Re)-search continues. JCO Precis Oncol 10.1200\/PO.23.00670","DOI":"10.1200\/PO.23.00670"},{"key":"e_1_3_2_68_2","doi-asserted-by":"publisher","DOI":"10.21037\/actr-25-80"},{"key":"e_1_3_2_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clcc.2024.04.004"},{"key":"e_1_3_2_70_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.25555"},{"key":"e_1_3_2_71_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc0904160"},{"key":"e_1_3_2_72_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6605164"},{"key":"e_1_3_2_73_2","doi-asserted-by":"publisher","DOI":"10.1358\/dot.2019.55.11.3035584"},{"key":"e_1_3_2_74_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djab042"},{"key":"e_1_3_2_75_2","doi-asserted-by":"publisher","DOI":"10.1038\/nsmb.2924"},{"key":"e_1_3_2_76_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbpa.2022.102205"},{"key":"e_1_3_2_77_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.63.2497"},{"key":"e_1_3_2_78_2","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-11-0341"},{"key":"e_1_3_2_79_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-2779"},{"key":"e_1_3_2_80_2","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-16-0050"},{"key":"e_1_3_2_81_2","doi-asserted-by":"publisher","unstructured":"Klute KA Rothe M Garrett-Mayer E et al: Cobimetinib plus vemurafenib in patients with colorectal cancer with BRAF mutations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study. JCO Precis Oncol 10.1200\/PO.22.00191","DOI":"10.1200\/PO.22.00191"},{"key":"e_1_3_2_82_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2021.12.028"},{"key":"e_1_3_2_83_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1908075"},{"key":"e_1_3_2_84_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2022.100477"},{"key":"e_1_3_2_85_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2501912"},{"key":"e_1_3_2_86_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.16_suppl.3517"},{"key":"e_1_3_2_87_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2025.08.002"},{"key":"e_1_3_2_88_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2026.44.2_suppl.13"},{"key":"e_1_3_2_89_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.01693"},{"key":"e_1_3_2_90_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-02181-8"},{"key":"e_1_3_2_91_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.01994"},{"key":"e_1_3_2_92_2","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-16-0795"},{"key":"e_1_3_2_93_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03235-9"},{"key":"e_1_3_2_94_2","first-page":"240","article-title":"A reversible SRC-relayed COX2 inflammatory program drives resistance to BRAF and EGFR inhibition in BRAFV600E colorectal tumors","volume":"4","author":"Ruiz-Saenz A","year":"2023","unstructured":"Ruiz-Saenz A, Atreya CE, Wang C, et al: A reversible SRC-relayed COX2 inflammatory program drives resistance to BRAF and EGFR inhibition in BRAFV600E colorectal tumors. Nat Cancer 4:240-256, 2023","journal-title":"Nat Cancer"},{"key":"e_1_3_2_95_2","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-13-0160"},{"key":"e_1_3_2_96_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2017699"},{"key":"e_1_3_2_97_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2402141"},{"key":"e_1_3_2_98_2","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2024-5056"},{"key":"e_1_3_2_99_2","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2024.2372886"},{"key":"e_1_3_2_100_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2025.43.16_suppl.3542"},{"key":"e_1_3_2_101_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0166583"},{"key":"e_1_3_2_102_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-023-00852-0"},{"key":"e_1_3_2_103_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2023.113458"},{"key":"e_1_3_2_104_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.0106"},{"key":"e_1_3_2_105_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2019.01.001"},{"key":"e_1_3_2_106_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-025-04117-1"},{"key":"e_1_3_2_107_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22010130"},{"key":"e_1_3_2_108_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0804588"},{"key":"e_1_3_2_109_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.16_suppl.3130"},{"key":"e_1_3_2_110_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(23)00150-X"},{"key":"e_1_3_2_111_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2023.41.16_suppl.3501"},{"key":"e_1_3_2_112_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38032-4"},{"key":"e_1_3_2_113_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(24)00380-2"},{"key":"e_1_3_2_114_2","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17091164"},{"key":"e_1_3_2_115_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01893-3"},{"key":"e_1_3_2_116_2","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-25-0682"},{"key":"e_1_3_2_117_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11030394"},{"key":"e_1_3_2_118_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2214963"},{"key":"e_1_3_2_119_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdt231"},{"key":"e_1_3_2_120_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2025.09.024"},{"key":"e_1_3_2_121_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(25)02025-2"},{"key":"e_1_3_2_122_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)00772-9"},{"key":"e_1_3_2_123_2","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2013-0107"},{"key":"e_1_3_2_124_2","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2024-2505"},{"key":"e_1_3_2_125_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(22)00274-1"},{"key":"e_1_3_2_126_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.02736"},{"key":"e_1_3_2_127_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2025.104775"},{"key":"e_1_3_2_128_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-3757"},{"key":"e_1_3_2_129_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2025.43.16_suppl.TPS3635"},{"key":"e_1_3_2_130_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-018-0665-y"},{"key":"e_1_3_2_131_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48479-8"},{"key":"e_1_3_2_132_2","doi-asserted-by":"publisher","DOI":"10.3390\/biom15050639"},{"key":"e_1_3_2_133_2","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2026.2622746"},{"key":"e_1_3_2_134_2","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-007785"},{"key":"e_1_3_2_135_2","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6074.IO2025-A107"},{"key":"e_1_3_2_136_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03083-7"},{"key":"e_1_3_2_137_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2025.43.4_suppl.23"},{"key":"e_1_3_2_138_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-25-0002"},{"key":"e_1_3_2_139_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-07984-4"},{"key":"e_1_3_2_140_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1705438"},{"key":"e_1_3_2_141_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO-24-02081"},{"key":"e_1_3_2_142_2","first-page":"777","article-title":"Colorectal cancer; novel approaches in chimeric antigen receptors (CAR)-T cell","volume":"14","author":"Haki M","year":"2025","unstructured":"Haki M, Darvishi M: Colorectal cancer; novel approaches in chimeric antigen receptors (CAR)-T cell. Int J Mol Cell Med 14:777-792, 2025","journal-title":"Int J Mol Cell Med"},{"key":"e_1_3_2_143_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2025.01.001"},{"key":"e_1_3_2_144_2","doi-asserted-by":"publisher","DOI":"10.1039\/D5RA02235E"},{"key":"e_1_3_2_145_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.4c02933"},{"key":"e_1_3_2_146_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers18010054"},{"key":"e_1_3_2_147_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-07334-4"},{"key":"e_1_3_2_148_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-025-02349-1"},{"key":"e_1_3_2_149_2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1513821"},{"key":"e_1_3_2_150_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2025.110926"}],"container-title":["American Society of Clinical Oncology Educational Book"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/EDBK-26-516576","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T19:59:14Z","timestamp":1777060754000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/EDBK-26-516576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":149,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10.1200\/EDBK-26-516576"],"URL":"https:\/\/doi.org\/10.1200\/edbk-26-516576","relation":{},"ISSN":["1548-8748","1548-8756"],"issn-type":[{"value":"1548-8748","type":"print"},{"value":"1548-8756","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6]]},"article-number":"e516576"}}